Pdcd10-Stk24/25 complex controls kidney water reabsorption by regulating Aqp2 membrane targeting
暂无分享,去创建一个
S. Alexander | J. J. Wong | Hua A. J. Lu | Zhiming Han | Xiangjian Zheng | Yin Xia | Renjing Liu | Yuzhen Zhang | Jaesung P. Choi | Yixuan Wang | Tao Zhuang | Xi Yang | Yude Qian | Rui Wang | Si-Yuan Song | Shi-Ting Wu | Rui Gao | Zhuang Tao
[1] Dennis Brown,et al. Targeting the Trafficking of Kidney Water Channels for Therapeutic Benefit. , 2020, Annual review of pharmacology and toxicology.
[2] C. Lengner,et al. Distinct cellular roles for PDCD10 define a gut-brain axis in cerebral cavernous malformation , 2019, Science Translational Medicine.
[3] H. Hirase,et al. Aquaporin-4-dependent glymphatic solute transport in the rodent brain , 2018, eLife.
[4] Sarah A. Teichmann,et al. Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors , 2018, Science.
[5] Dennis Brown,et al. Ezrin directly interacts with AQP2 and promotes its endocytosis , 2017, Journal of Cell Science.
[6] A. Levchenko,et al. Combined HMG-COA reductase and prenylation inhibition in treatment of CCM , 2017, Proceedings of the National Academy of Sciences.
[7] R. Fenton,et al. Aquaporin-2 membrane targeting: still a conundrum. , 2017, American journal of physiology. Renal physiology.
[8] K. Takata,et al. The distribution and function of aquaporins in the kidney: resolved and unresolved questions , 2017, Anatomical Science International.
[9] C. Marshall,et al. RHO binding to FAM65A regulates Golgi reorientation during cell migration , 2016, Journal of Cell Science.
[10] S. Sasaki,et al. Wnt5a induces renal AQP2 expression by activating calcineurin signalling pathway , 2016, Nature Communications.
[11] R. Fenton,et al. The vasopressin type 2 receptor and prostaglandin receptors EP2 and EP4 can increase aquaporin-2 plasma membrane targeting through a cAMP-independent pathway. , 2016, American journal of physiology. Renal physiology.
[12] Dennis Brown,et al. EGF Receptor Inhibition by Erlotinib Increases Aquaporin 2-Mediated Renal Water Reabsorption. , 2016, Journal of the American Society of Nephrology : JASN.
[13] E. Klussmann,et al. The Trafficking of the Water Channel Aquaporin-2 in Renal Principal Cells—a Potential Target for Pharmacological Intervention in Cardiovascular Diseases , 2016, Front. Pharmacol..
[14] D. Bichet,et al. Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus , 2015, Nature Reviews Nephrology.
[15] Devin K. Binder,et al. Expression of the Astrocyte Water Channel Aquaporin-4 in the Mouse Brain , 2015, ASN neuro.
[16] O. Devuyst,et al. Molecular Physiology of Water Balance. , 2015, The New England journal of medicine.
[17] T. Boggon,et al. CCM2–CCM3 interaction stabilizes their protein expression and permits endothelial network formation , 2015, The Journal of cell biology.
[18] A. Gingras,et al. CCM-3/STRIPAK promotes seamless tube extension through endocytic recycling , 2015, Nature Communications.
[19] Paul A. Bates,et al. STRIPAK components determine mode of cancer cell migration and metastasis , 2014, Nature Cell Biology.
[20] R. Shenkar,et al. EXCEPTIONAL AGGRESSIVENESS OF CEREBRAL CAVERNOUS MALFORMATION DISEASE ASSOCIATED WITH PDCD10 MUTATIONS , 2014, Genetics in Medicine.
[21] R. Fenton,et al. Renal aquaporins and water balance disorders. , 2014, Biochimica et biophysica acta.
[22] A. Louvi,et al. Ccm3, a gene associated with cerebral cavernous malformations, is required for neuronal migration , 2014, Development.
[23] Yingke Xu,et al. A network of interactions enables CCM3 and STK24 to coordinate UNC13D-driven vesicle exocytosis in neutrophils. , 2013, Developmental cell.
[24] A. Ghabrial,et al. Focal defects in single-celled tubes mutant for Cerebral cavernous malformation 3, GCKIII, or NSF2. , 2013, Developmental cell.
[25] J. Zalvide,et al. Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis. , 2013, Trends in molecular medicine.
[26] Lan Cheng,et al. Dynamic regulation of the cerebral cavernous malformation pathway controls vascular stability and growth. , 2012, Developmental cell.
[27] E. Dejana,et al. Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice , 2011, The Journal of experimental medicine.
[28] R. Fehon,et al. Ezrin, Radixin and Moesin: key regulators of membrane-cortex interactions and signaling. , 2011, Current opinion in cell biology.
[29] Amber N. Stratman,et al. Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice. , 2011, The Journal of clinical investigation.
[30] W. Min,et al. Loss of cerebral cavernous malformation 3 (Ccm3) in neuroglia leads to CCM and vascular pathology , 2011, Proceedings of the National Academy of Sciences.
[31] W. Sessa,et al. CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations. , 2010, The Journal of clinical investigation.
[32] T. Force,et al. CCM3/PDCD10 stabilizes GCKIII proteins to promote Golgi assembly and cell orientation , 2010, Journal of Cell Science.
[33] W. Min,et al. Stabilization of VEGFR2 Signaling by Cerebral Cavernous Malformation 3 Is Critical for Vascular Development , 2010, Science Signaling.
[34] Brian Raught,et al. A PP2A Phosphatase High Density Interaction Network Identifies a Novel Striatin-interacting Phosphatase and Kinase Complex Linked to the Cerebral Cavernous Malformation 3 (CCM3) Protein*S , 2009, Molecular & Cellular Proteomics.
[35] Dennis Brown,et al. NF-κB Modulates Aquaporin-2 Transcription in Renal Collecting Duct Principal Cells* , 2008, Journal of Biological Chemistry.
[36] Dennis Brown,et al. Bypassing vasopressin receptor signaling pathways in nephrogenic diabetes insipidus. , 2008, Seminars in nephrology.
[37] A S Verkman,et al. Three distinct roles of aquaporin-4 in brain function revealed by knockout mice. , 2006, Biochimica et biophysica acta.
[38] R. Schrier. Body water homeostasis: clinical disorders of urinary dilution and concentration. , 2006, Journal of the American Society of Nephrology : JASN.
[39] Geoffrey T. Manley,et al. Involvement of aquaporin-4 in astroglial cell migration and glial scar formation , 2005, Journal of Cell Science.
[40] G. Tamma,et al. Actin remodeling requires ERM function to facilitate AQP2 apical targeting , 2005, Journal of Cell Science.
[41] J. Loffing,et al. Mineralocorticoid versus glucocorticoid receptor occupancy mediating aldosterone-stimulated sodium transport in a novel renal cell line. , 2005, Journal of the American Society of Nephrology : JASN.
[42] E. Bruyneel,et al. YSK1 is activated by the Golgi matrix protein GM130 and plays a role in cell migration through its substrate 14-3-3ζ , 2004, The Journal of cell biology.
[43] P. Igarashi,et al. Epithelial-specific Cre/lox recombination in the developing kidney and genitourinary tract. , 2002, Journal of the American Society of Nephrology : JASN.
[44] P. Igarashi,et al. A minimal Ksp-cadherin promoter linked to a green fluorescent protein reporter gene exhibits tissue-specific expression in the developing kidney and genitourinary tract. , 2002, Journal of the American Society of Nephrology : JASN.
[45] Shankar Srinivas,et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus , 2001, BMC Developmental Biology.
[46] M. Mclaughlin,et al. Nitric oxide and atrial natriuretic factor stimulate cGMP-dependent membrane insertion of aquaporin 2 in renal epithelial cells. , 2000, The Journal of clinical investigation.
[47] P. Sluijs,et al. An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex. , 1998, The Journal of clinical investigation.
[48] M. Mclaughlin,et al. Calcitonin has a vasopressin-like effect on aquaporin-2 trafficking and urinary concentration. , 2011, Journal of the American Society of Nephrology : JASN.
[49] J. G. Verbalis,et al. Diabetes insipidus. , 1997, Current therapy in endocrinology and metabolism.